bosentan anhydrous has been researched along with Hereditary Hemorrhagic Telangiectasia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cachulo, Mdo C; Costa, GV; Leitão-Marques, AM; Lemos, CG; Providência, R; Silva, J | 1 |
Chang, SA; Jang, SY; Kang, IS; Ki, CS; Kim, DK | 1 |
Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R | 1 |
Adlbrecht, C; Bonderman, D; Lang, IM; Nowotny, R; Skoro-Sajer, N | 1 |
4 other study(ies) available for bosentan anhydrous and Hereditary Hemorrhagic Telangiectasia
Article | Year |
---|---|
Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?
Topics: Aged; Antihypertensive Agents; Bosentan; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic | 2010 |
Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bosentan; Echocardiography, Doppler; Endothelin Receptor Antagonists; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Recovery of Function; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents | 2005 |
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Middle Aged; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Outcome | 2006 |